EO-3021
- Generic Name
- EO-3021
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Elevation Oncology
- Target Recruit Count
- 120
- Registration Number
- NCT05980416
- Locations
- 🇰🇷
Samsung Medical Center, Gangnam-Gu, Korea, Republic of
🇰🇷Yonsei University, Seodaemun-gu, Korea, Republic of
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath